It is currently Wed Apr 23, 2014 10:38 am

News News of Gilenya

Site map of Gilenya » Forum : Gilenya

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.

MSRC Launch Gilenya User Diaries

Image

MSRC Launch Gilenya User Diaries.

Following on from the success of our Tysabri User Diaries in providing personal experiences of MSers on a drug, MSRC have today launched a new facility for those taking, or thinking of taking Gilenya, the first approved oral MS medication. http://www.msrc.co.uk/index.cfm/fuseact ... geid/3403/

Kim has become our first diarist and you can read her page at http://www.msrc.co.uk/index.cfm/fuseact ... ageid/3404 ...
Read more : MSRC Launch Gilenya User Diaries | Views : 1948 | Replies : 7


Calls for Gilenya to be made available in Ireland

Image

The Multiple Sclerosis Society of Ireland (MS Ireland) has called on the government to make available in Ireland a controversial drug that it believes would much more effectively treat some forms of the disease.

The call, echoed by the drug’s manufacturer, follows the decision by the National Institute for Health and Clinical Excellence (NICE) in the UK to recommend that the drug, fingolimod - known by its brand name Gilenya - , be available ...
Read more : Calls for Gilenya to be made available in Ireland | Views : 1161 | Replies : 0


Scottish MS Society will challenge Gilenya decision

Image


Multiple sclerosis campaigners will step up their bid to persuade Scotland’s medicines regulator to overturn its decision to reject a new treatment for the disease.

The Multiple Sclerosis Society Scotland yesterday said it would be writing to the Scottish Medicines Consortium (SMC) to try to convince the regulator it should approve the use of fingolimod.

Pressure mounted on the SMC after its equivalent body south of the Border, the National Institute for Health and ...
Read more : Scottish MS Society will challenge Gilenya decision | Views : 1156 | Replies : 1


NICE backs new oral MS drug, Gilenya

Image


Novartis's multiple sclerosis pill Gilenya has been recommended for use on the U.K.'s publicly-funded National Health Service after a change of heart by the country's healthcare cost-effectiveness watchdog.

Friday's verdict from the National Institute for Health and Clinical Excellence, whose opinions are also watched closely in other countries, is welcome news for the Swiss company's potential blockbuster product whose safety profile has come into question recently.

NICE said it changed its mind on the ...
Read more : NICE backs new oral MS drug, Gilenya | Views : 1076 | Replies : 0


SMC turns down oral MS drug Gilenya

Image

The Scottish Medicines Consortium (SMC) yesterday rejected recommending the prescribing of the first oral pill for sufferers of multiple sclerosis in Scotland.

The SMC said that, while the manufacturers of Gilenya, had provided evidence about it helping to reduce relapse rates, they had not compared it with another drug commonly used in Scotland.

It added that evidence showed that starting treatment with Fingolimod could cause a short-term decrease in heart rate and swelling of ...
Read more : SMC turns down oral MS drug Gilenya | Views : 1411 | Replies : 0


Scottish decision due on oral MS drug Gilenya

Image

The Scottish Medicines Consortium (SMC) will decide on today if it will recommend the prescribing of the first oral pill for the treatment of Multiple Sclerosis in Scotland.

Currently, suffers face painful daily injections deep into the muscle or having to travel to hospital for infusion therapy to try to control the disease, which damages the central nervous system, causing a range of disabilities such as problems with co-ordination, speech and vision.

But this ...
Read more : Scottish decision due on oral MS drug Gilenya | Views : 1043 | Replies : 0


Deaths hit oral MS drug, Gilenya

Image


Novartis AG's Gilenya multiple sclerosis pill lost market share for the first time in January, following the deaths of some patients soon after taking the first pill available for the disease in the United States.

Gilenya's share of the U.S. market for so-called immunomodulatory drugs against MS fell to 6.1 percent from 6.2 percent in December, according to data from Wolters Kluwer NV, a market research company. The decline was the first after 15 ...
Read more : Deaths hit oral MS drug, Gilenya | Views : 1691 | Replies : 0


Safety of oral MS pill Gilenya reviewed after deaths

Image

Health Canada is reviewing a new multiple sclerosis drug that has been linked to 11 deaths.

There have been no reports of deaths in Canada of people taking the Novartis drug, which is sold under the brand name Gilenya.

Health Canada says that of the deaths outside the country, it's not clear whether the drug itself caused them, or whether other factors played a role.

Both the U.S. Food and Drug Administration and the ...
Read more : Safety of oral MS pill Gilenya reviewed after deaths | Views : 1484 | Replies : 0


A randomized, controlled trial of fingolimod in Japanese MS

A randomized, controlled trial of fingolimod (FTY720) in Japanese MS patients

Image


Abstract
Background: Fingolimod (FTY720) has previously shown clinical efficacy in phase II/III studies of predominantly Caucasian populations with multiple sclerosis (MS).

Objectives: To report six-month efficacy and safety outcomes in Japanese patients with relapsing MS treated with fingolimod.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309
Read more : A randomized, controlled trial of fingolimod in Japanese MS | Views : 1545 | Replies : 0


EU says MS drug Gilenya needs heart monitoring

Image

The European Medicines Agency advised doctors to continuously monitor patients for six hours after giving them a first dose of Novartis AG's multiple sclerosis drug Gilenya, casting a shadow over the potential blockbuster product.

The move came as the organisation started a review into the safety of the medicine, following reports of heart problems in patients and the death of one person in the United States within 24 hours of starting treatment.

The Swiss ...
Read more : EU says MS drug Gilenya needs heart monitoring | Views : 1438 | Replies : 1


 

Login  •  Register


Statistics

Total posts 216595 • Total topics 22130 • Total members 13918